ロード中...
Recurrent ganglioglioma in adults treated with BRAF inhibitors
Thirteen adult patients with temozolomide, surgery and radiation refractory ganglioglioma were screened for the BRAF V600E mutation. Three (23%) were found positive for the presence of the BRAF mutation and were treated with the BRAF inhibitor dabrafenib. Dabrafenib was well tolerated with no grade...
保存先:
| 出版年: | CNS Oncol |
|---|---|
| 第一著者: | |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Future Medicine Ltd
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6078155/ https://ncbi.nlm.nih.gov/pubmed/26680369 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/cns.15.40 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|